Multivariate analysis of traumatic brain injury: Development of an assessment score

Frontiers in Neurology

Volumn 6, Issue MAR, 2015, Pages

  Buonora, John E ^a,b   Yarnell, Angela M ^c   Lazarus, Rachel C ^a   Mousseau, Michael ^a   Latour, Lawrence L ^d,e   Rizoli, Sandro B ^f   Baker, Andrew J ^g   Rhind, Shawn G ^e   Diaz Arrastia, Ramon ^a   Mueller, Gregory P ^a  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^b BAYLOR UNIVERSITY   (United States)

^c WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^d NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^e DEFENCE RESEARCH AND DEVELOPMENT CANADA   (Canada)

^f ST MICHAEL'S HOSPITAL   (Canada)

^g ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

Assessment score; Biomarkers; Human; Mild traumatic brain injury; Multivariate analysis

Indexed keywords

BIOLOGICAL MARKER; BRAIN DERIVED NEUROTROPHIC FACTOR; GLIAL FIBRILLARY ACIDIC PROTEIN; INTERCELLULAR ADHESION MOLECULE 5; LYMPHOCYTE ANTIGEN; MONOCYTE CHEMOTACTIC PROTEIN 1; NEURON SPECIFIC ENOLASE; PEROXIREDOXIN 6; PROTEIN S 100; PROTEIN S100B; UNCLASSIFIED DRUG;

ADULT; AMNESIA; AREA UNDER THE CURVE; ARTICLE; CLINICAL ASSESSMENT; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FALLING; FEMALE; GLASGOW COMA SCALE; HEAD INJURY; HUMAN; LIMIT OF DETECTION; LIMIT OF QUANTITATION; MAJOR CLINICAL STUDY; MALE; NERVOUS SYSTEM INJURY; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; OXIDATIVE STRESS; PROTEIN EXPRESSION; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; TRAFFIC ACCIDENT; TRAUMATIC BRAIN INJURY; UNCONSCIOUSNESS;

EID: 84926479794     PISSN: None     EISSN: 16642295     Source Type: Journal    
DOI: 10.3389/fneur.2015.00068     Document Type: Article

References (67)

1. Mondello S, Schmid K, Berger RP, Kobeissy F, Italiano D, Jeromin A, et al. The challenge of mild traumatic brain injury: role of biochemical markers in diagnosis of brain damage. Med Res Rev (2014) 34:503-31. doi: 10.1002/med.21295
2. Werner C, Engelhard K. Pathophysiology of traumatic brain injury. Br J Anaesth (2007) 99:4-9. doi:10.1093/bja/aem131
3. Kabadi SV, Faden AI. Neuroprotective strategies for traumatic brain injury: improving clinical translation. Int J Mol Sci (2014) 15:1216-36. doi:10.3390/ijms15011216
4. Shetty AK, Mishra V, Kodali M, Hattiangady B. Blood brain barrier dysfunction and delayed neurological deficits in mild traumatic brain injury induced by blast shock waves. Front Cell Neurosci (2014) 8:232. doi:10.3389/fncel.2014.00232
5. Arciniegas DB, Anderson CA, Topkoff J, McAllister TW. Mild traumatic brain injury: a neuropsychiatric approach to diagnosis, evaluation, and treatment. Neuropsychiatr Dis Treat (2005) 1:311-27.
6. Tait RJ, Anstey KJ, Butterworth P. Incidence of self-reported brain injury and the relationship with substance abuse: findings from a longitudinal community survey. BMC Public Health (2010) 10:171. doi:10.1186/1471-2458-10-171
7. Katz RT, Deluca J. Sequelae of minor traumatic brain injury. Am Fam Physician (1992) 46:1491-8.
8. Dikmen S, Machamer J, Temkin N. Mild head injury: facts and artifacts. J Clin Exp Neuropsychol (2001) 23:729-38. doi:10.1076/jcen.23.6.729.1019
9. Tolonen A, Turkka J, Salonen O, Ahoniemi E, Alaranta H. Traumatic brain injury is under-diagnosed in patients with spinal cord injury. J Rehabil Med (2007) 39:622-6. doi:10.2340/16501977-0101
10. Doppenberg EM, Choi SC, Bullock R. Clinical trials in traumatic brain injury. What can we learn from previous studies? Ann N Y Acad Sci (1997) 825:305-22. doi:10.1111/j.1749-6632.1997.tb48441.x
11. Narayan RK, Michel ME, Ansell B, Baethmann A, Biegon A, Bracken MB, et al. Clinical trials in head injury. J Neurotrauma (2002) 19:503-57. doi:10.1089/089771502753754037
12. Marshall LF, Marshall SB, Klauber MR, Van Berkum Clark M, Eisenberg H, Jane JA, et al. The diagnosis of head injury requires a classification based on computed axial tomography. J Neurotrauma (1992) 9(Suppl 1):S287-92.
13. Cook GA, Hawley JS. A review of mild traumatic brain injury diagnostics: current perspectives, limitations, and emerging technology. Mil Med (2014) 179:1083-9. doi:10.7205/milmed-d-13-00435
14. Servadei F, Teasdale G, Merry G. Defining acute mild head injury in adults: a proposal based on prognostic factors, diagnosis, and management. J Neurotrauma (2001) 18:657-64. doi:10.1089/089771501750357609
15. Bruce J, Echemendia R, Meeuwisse W, Comper P, Sisco A. 1 year test-retest reliability of ImPACT in professional ice hockey players. Clin Neuropsychol (2014) 28:14-25. doi:10.1080/13854046.2013.866272
16. Di Battista AP, Rhind SG, Baker AJ. Application of blood-based biomarkers in human mild traumatic brain injury. Front Neurol (2013) 4:44. doi:10.3389/fneur.2013.00044
17. Rothoerl RD, Woertgen C, Holzschuh M, Metz C, Brawanski A. S-100 serum levels after minor and major head injury. J Trauma (1998) 45:765-7. doi:10.1097/00005373-199810000-00025
18. Bazarian JJ, Beck C, Blyth B, Von Ahsen N, Hasselblatt M. Impact of creatine kinase correction on the predictive value of S-100B after mild traumatic brain injury. Restor Neurol Neurosci (2006) 24:163-72.
19. Hergenroeder GW, Redell JB, Moore AN, Dash PK. Biomarkers in the clinical diagnosis and management of traumatic brain injury. Mol Diagn Ther (2008) 12:345-58. doi:10.1007/BF03256301
20. Carr ME Jr, Masullo LN, Brown JK, Lewis PC. Creatine kinase BB isoenzyme blood levels in trauma patients with suspected mild traumatic brain injury. Mil Med (2009) 174:622-5. doi:10.7205/MILMED-D-02-4708
21. Papa L, Lewis LM, Falk JL, Zhang Z, Silvestri S, Giordano P, et al. Elevated levels of serum glial fibrillary acidic protein breakdown products in mild and moderate traumatic brain injury are associated with intracranial lesions and neurosurgical intervention. Ann Emerg Med (2011) 59(6):471-83. doi:10.1016/j.annemergmed.2011.08.021
22. Ross SA, Cunningham RT, Johnston CF, Rowlands BJ. Neuron-specific enolase as an aid to outcome prediction in head injury. Br J Neurosurg (1996) 10:471-6. doi:10.1080/02688699647104
23. Romner B, Ingebrigtsen T. High serum S100B levels for trauma patients without head injuries. Neurosurgery (2001) 49:1490. doi:10.1097/00006123-200112000-00053
24. Pelinka LE, Kroepfl A, Leixnering M, Buchinger W, Raabe A, Redl H. GFAP versus S100B in serum after traumatic brain injury: relationship to brain damage and outcome. J Neurotrauma (2004) 21:1553-61. doi:10.1089/neu.2004.21.1553
25. Pelinka LE, Kroepfl A, Schmidhammer R, Krenn M, Buchinger W, Redl H, et al. Glial fibrillary acidic protein in serum after traumatic brain injury and multiple trauma. J Trauma (2004) 57:1006-12. doi:10.1097/01.TA.0000108998.48026.C3
26. Agoston DV, Elsayed M. Serum-based protein biomarkers in blast-induced traumatic brain injury spectrum disorder. Front Neurol (2012) 3:107. doi:10.3389/fneur.2012.00107
27. Feala JD, Abdulhameed MDM, Yu C, Dutta B, Yu X, Schmid K, et al. Systems biology approaches for discovering biomarkers for traumatic brain injury. J Neurotrauma (2013) 30:1101-16. doi:10.1089/neu.2012.2631
28. Diaz-Arrastia R, Wang KK, Papa L, Sorani MD, Yue JK, Puccio AM, et al. Acute biomarkers of traumatic brain injury: relationship between plasma levels of ubiquitin C-terminal hydrolase-L1 and glial fibrillary acidic protein. J Neurotrauma (2014) 31:19-25. doi:10.1089/neu.2013.3040
29. Guo H, Tong N, Turner T, Epstein LG, McDermott MP, Kilgannon P, et al. Release of the neuronal glycoprotein ICAM-5 in serum after hypoxic-ischemic injury. Ann Neurol (2000) 48:590-602. doi:10.1002/1531-8249(200010)48:4<590::AID-ANA5>3.3.CO;2-Z
30. Manevich Y, Hutchens S, Halushka PV, Tew KD, Townsend DM, Jauch EC, et al. Peroxiredoxin VI oxidation in cerebrospinal fluid correlates with traumatic brain injury outcome. Free Radic Biol Med (2014) 72:210-21. doi:10.1016/j.freeradbiomed.2014.04.002
31. Guzel A, Er U, Tatli M, Aluclu U, Ozkan U, Duzenli Y, et al. Serum neuron-specific enolase as a predictor of short-term outcome and its correlation with Glasgow coma scale in traumatic brain injury. Neurosurg Rev (2008) 31:439-44. doi:10.1007/s10143-008-0148-2
32. El-Maraghi S, Yehia H, Hossam H, Yehia A, Mowafy H. The prognostic value of neuron specific enolase in head injury. The Egypt J Crit Care Med (2013) 1:25-32. doi:10.1016/j.ejccm.2012.12.002
33. Guingab-Cagmat J, Cagmat E, Hayes RL, Anagli J. Integration of proteomics, bioinformatics and systems biology in brain injury biomarker discovery. Front Neurol (2013) 4:61. doi:10.3389/fneur.2013.00061
34. Tator CH. Strategies for recovery and regeneration after brain and spinal cord injury. Inj Prev (2002) 8:iv33-6. doi:10.1136/ip.8.suppl_4.iv33
35. Ploughman M, Windle V, Maclellan CL, White N, Doré JJ, Corbett D. Brain-derived neurotrophic factor contributes to recovery of skilled reaching after focal ischemia in rats. Stroke (2009) 40:1490-5. doi:10.1161/strokeaha.108.531806
36. Goemaere J, Knoops B. Peroxiredoxin distribution in the mouse brain with emphasis on neuronal populations affected in neurodegenerative disorders. J Comp Neurol (2012) 520:258-80. doi:10.1002/cne.22689
37. Chen Y, Swanson RA. Astrocytes and brain injury. J Cereb Blood Flow Metab (2003) 23:137-49. doi:10.1097/00004647-200302000-00001
38. Selenica M-L, Alvarez J, Nash K, Lee D, Cao C, Lin X, et al. Diverse activation of microglia by chemokine (C-C motif) ligand 2 overexpression in brain. J Neuroinflammation (2013) 10:86. doi:10.1186/1742-2094-10-86
39. Kim RY, Hoffman AS, Itoh N, Ao Y, Spence R, Sofroniew MV, et al. Astrocyte CCL2 sustains immune cell infiltration in chronic experimental autoimmune encephalomyelitis. J Neuroimmunol (2014) 274:53-61. doi:10.1016/j.jneuroim.2014.06.009
40. Yang H. Structure, expression, and function of ICAM-5. Comp Funct Genomics (2012) 2012:368938. doi:10.1155/2012/368938
41. Ning L, Tian L, Smirnov S, Vihinen H, Llano O, Vick K, et al. Interactions between ICAM-5 and β1 integrins regulate neuronal synapse formation. J Cell Sci (2013) 126:77-89. doi:10.1242/jcs.106674
42. Blyth BJ, Bazarian JJ. Traumatic alterations in consciousness: traumatic brain injury. Emerg Med Clin North Am (2010) 28:571-94. doi:10.1016/j.emc.2010.03.003
43. Biberthaler P, Linsenmeier U, Pfeifer KJ, Kroetz M, Mussack T, Kanz KG, et al. Serum S-100B concentration provides additional information fot the indication of computed tomography in patients after minor head injury: a prospective multicenter study. Shock (2006) 25:446-53. doi:10.1097/01.shk.0000209534.61058.35
44. Papa L, Akinyi L, Liu MC, Pineda JA, Tepas JJ III, Oli MW, et al. Ubiquitin C-terminal hydrolase is a novel biomarker in humans for severe traumatic brain injury. Crit Care Med (2010) 38:138-44. doi:10.1097/CCM.0b013e3181b788ab
45. Siman R, Toraskar N, Dang A, McNeil E, McGarvey M, Plaum J, et al. A panel of neuron-enriched proteins as markers for traumatic brain injury in humans. J Neurotrauma (2009) 26:1867-77. doi:10.1089/neu.2009.0882
46. Gyorgy A, Ling G, Wingo D, Walker J, Tong L, Parks S, et al. Time-dependent changes in serum biomarker levels after blast traumatic brain injury. J Neurotrauma (2011) 28:1121-6. doi:10.1089/neu.2010.1561
47. Vos PE, Lamers KJ, Hendriks JC, Van Haaren M, Beems T, Zimmerman C, et al. Glial and neuronal proteins in serum predict outcome after severe traumatic brain injury. Neurology (2004) 62:1303-10. doi:10.1212/01.WNL.0000120550.00643.DC
48. Kleindienst A, Hesse F, Bullock MR, Buchfelder M. The neurotrophic protein S100B: value as a marker of brain damage and possible therapeutic implications. Prog Brain Res (2007) 161:317-25. doi:10.1016/s0079-6123(06)61022-4
49. Fatma N, Kubo E, Toris CB, Stamer WD, Camras CB, Singh DP. PRDX6 attenuates oxidative stress- and TGFbeta-induced abnormalities of human trabecular meshwork cells. Free Radic Res (2009) 43:783-95. doi:10.1080/10715760903062887
50. Chhunchha B, Fatma N, Kubo E, Rai P, Singh SP, Singh DP. Curcumin abates hypoxia-induced oxidative stress based-ER stress-mediated cell death in mouse hippocampal cells (HT22) by controlling Prdx6 and NF-kappaB regulation. Am J Physiol Cell Physiol (2013) 304:C636-55. doi:10.1152/ajpcell.00345.2012
51. Conductier G, Blondeau N, Guyon A, Nahon JL, Rovere C. The role of monocyte chemoattractant protein MCP1/CCL2 in neuroinflammatory diseases. J Neuroimmunol (2010) 224:93-100. doi:10.1016/j.jneuroim.2010.05.010
52. Stalnacke BM, Tegner Y, Sojka P. Playing ice hockey and basketball increases serum levels of S-100B in elite players: a pilot study. Clin J Sport Med (2003) 13:292-302. doi:10.1097/00042752-200309000-00004
53. Graham MR, Myers T, Evans P, Davies B, Cooper SM, Bhattacharya K, et al. Direct hits to the head during amateur boxing is associated with a rise in serum biomarkers for brain injury. Int J Immunopathol Pharmacol (2011) 24:119-25.
54. Zetterberg H, Smith DH, Blennow K. Biomarkers of mild traumatic brain injury in cerebrospinal fluid and blood. Nat Rev Neurol (2013) 9:201-10. doi:10.1038/nrneurol.2013.9
55. Chase A. Traumatic brain injury: blood biomarkers for assessing concussion in professional hockey players. Nat Rev Neurol (2014) 10:240. doi:10.1038/nrneurol.2014.65
56. Rostami E, Davidsson J, Ng KC, Lu J, Gyorgy A, Wingo D, et al. A model for mild traumatic brain injury that induces limited transient memory impairment and increased levels of axon related serum biomarkers. Front Neurol (2012) 3:115. doi:10.3389/fneur.2012.00115
57. Dekosky ST, Blennow K, Ikonomovic MD, Gandy S. Acute and chronic traumatic encephalopathies: pathogenesis and biomarkers. Nat Rev Neurol (2013) 9:192-200. doi:10.1038/nrneurol.2013.36
58. Sofroniew MV, Vinters HV. Astrocytes: biology and pathology. Acta Neuropathol (2010) 119:7-35. doi:10.1007/s00401-009-0619-8
59. Day IN, Thompson RJ. Levels of immunoreactive aldolase C, creatine kinase-BB, neuronal and non-neuronal enolase, and 14-3-3 protein in circulating human blood cells. Clin Chim Acta (1984) 136:219-28. doi:10.1016/0009-8981(84)90295-X
60. Fujimura H, Altar CA, Chen R, Nakamura T, Nakahashi T, Kambayashi J, et al. Brain-derived neurotrophic factor is stored in human platelets and released by agonist stimulation. Thromb Haemost (2002) 87:728-34.
61. Sedaghat F, Notopoulos A. S100 protein family and its application in clinical practice. Hippokratia (2008) 12:198-204.
62. Cirillo C, Sarnelli G, Esposito G, Turco F, Steardo L, Cuomo R. S100B protein in the gut: the evidence for enteroglial-sustained intestinal inflammation. World J Gastroenterol (2011) 17:1261-6. doi:10.3748/wjg.v17.i10.1261
63. Kent C, Rowe HL. The immunolocalisation of ubiquitin carboxyl-terminal hydrolase (PGP9.5) in developing paraneurons in the rat. Brain Res Dev Brain Res (1992) 68:241-6. doi:10.1016/0165-3806(92)90066-6
64. Papa L, Lewis LM, Silvestri S, Falk JL, Giordano P, Brophy GM, et al. Serum levels of ubiquitin C-terminal hydrolase distinguish mild traumatic brain injury from trauma controls and are elevated in mild and moderate traumatic brain injury patients with intracranial lesions and neurosurgical intervention. J Trauma Acute Care Surg (2012) 72:1335-44. doi:10.1097/TA.0b013e3182491e3d
65. Newman TA, Bailey JL, Stocker LJ, Woo YL, Macklon NS, Cheong YC. Expression of neuronal markers in the endometrium of women with and those without endometriosis. Hum Reprod (2013) 28(9):2502-10. doi:10.1093/humrep/det274
66. Xu Y, Hideshima M, Ishii Y, Yoshikawa Y, Kyuwa S. Ubiquitin C-terminal hydrolase l1 is expressed in mouse pituitary gonadotropes in vivo and gonadotrope cell lines in vitro. Exp Anim (2014) 63:247-56. doi:10.1538/expanim.63.247
67. Topolovec-Vranic J, Pollmann-Mudryj MA, Ouchterlony D, Klein D, Spence J, Romaschin A, et al. The value of serum biomarkers in prediction models of outcome after mild traumatic brain injury. J Trauma (2011) 71:S478-86. doi:10.1097/TA.0b013e318232fa70